Oncosem Rapid Antigen Test COVID-19 Antigen Rapid Test Device detects the presence of SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions. In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.
Antigen-detection diagnostic tests are designed to directly detect SARSCoV-2 proteins produced by replicating virus in respiratory secretions and have been developed as both laboratory-based tests, and for near-patient use, socalled rapid diagnostic test.
COVID-19 Antigen Test (CAT) named Rapid SARSCoV- 2 Antigen Test is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 virus antigen in nasopharyngeal / oropharyngeal swabs from individuals suspected of COVID-19 within the first seven days of symptom onset.